Rivastigmine in Parkinson’s Disease DementiaProfile Report

被引:0
|
作者
M. Asif A. Siddiqui
Antona J. Wagstaff
机构
[1] Wolters Kluwer Health | Adis,
[2] editorial office of Wolters Kluwer Health,undefined
来源
Drugs & Aging | 2007年 / 24卷
关键词
Dementia; Mild Cognitive Impairment; Dementia With Lewy Body; Rivastigmine; Cholinergic Deficit;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:255 / 259
页数:4
相关论文
共 50 条
  • [1] Rivastigmine in Parkinson's disease dementia
    Chitnis, Shilpa
    Rao, Jayaraman
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2009, 5 (08) : 941 - 955
  • [2] Rivastigmine - In Parkinson's disease dementia
    Siddiqui, M. Asif A.
    Wagstaff, Antona J.
    [J]. CNS DRUGS, 2006, 20 (09) : 739 - 747
  • [3] Rivastigmine in Parkinson's disease dementia
    Siddiqui, M. Asif A.
    Wagstaff, Antona J.
    Emre, Murat
    Poewe, Werner
    Aarsland, Dag
    [J]. DRUGS & AGING, 2007, 24 (03) : 255 - 259
  • [4] Rivastigmine for dementia associated with Parkinson's disease
    Emre, M
    Aarsland, D
    Albanese, A
    Byrne, EJ
    Deuschl, G
    De Deyn, PP
    Durif, F
    Kulisevsky, J
    van Laar, T
    Lees, A
    Poewe, W
    Robillard, A
    Rosa, MM
    Wolters, E
    Quarg, P
    Tekin, S
    Lane, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (24): : 2509 - 2518
  • [5] Rivastigmine for visual hallucinations in Parkinson's disease
    Mierlo, T.
    Foncke, E.
    Bie, R.
    [J]. MOVEMENT DISORDERS, 2019, 34 : S66 - S67
  • [6] Rivastigmine (Exelon) for dementia in patients with Parkinson's disease
    Giladi, N
    Shabtai, H
    Gurevich, T
    Benbunan, B
    Anca, M
    Korczyn, AD
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 2003, 108 (05): : 368 - 373
  • [7] Rivastigmine in Parkinson's Disease Dementia with Orthostatic Hypotension
    Espay, Alberto J.
    Marsili, Luca
    Mahajan, Abhimanyu
    Sturchio, Andrea
    Pathan, Rashidkhan
    Pilotto, Andrea
    Elango, Damodaran S.
    Pezous, Nicole
    Masellis, Mario
    Gomez-Mancilla, Baltazar
    [J]. ANNALS OF NEUROLOGY, 2021, 89 (01) : 91 - 98
  • [8] Rivastigmine for dementia associated with Parkinson's disease.
    Morgan J.
    Sethi K.D.
    [J]. Current Neurology and Neuroscience Reports, 2005, 5 (4) : 263 - 265
  • [9] Rivastigmine for dementia associated with Parkinson's Disease.
    Harada, CN
    Shega, JW
    Sachs, GA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (13): : 1387 - 1387
  • [10] Open long-term treatment with rivastigmine in Parkinson's disease: report of six cases
    Hahn, K.
    Ebersbach, G.
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2007, 114 (03) : XIV - XIV